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Available online 19 March 2008Guanine nucleotide-binding proteins, G proteins, propagate incoming messages from receptors to effector
proteins. They switch from an inactive to active state by exchanging a GDPmolecule for GTP, and they return to
the inactive form by hydrolyzing GTP to GDP. Small monomeric G proteins, such as Ras, are involved in
controlling cell proliferation, differentiation and apoptosis, and they interact with membranes through
isoprenyl moieties, fatty acyl moieties, and electrostatic interactions. This protein–lipid binding facilitates
productive encounters of Ras and Raf proteins in deﬁned membrane regions, so that signals can subsequently
proceed through MEK and ERK kinases, which constitute the canonical MAP kinase signaling cassette. On the
other hand, heterotrimeric G proteins undergo co/post-translational modiﬁcations in the alpha (myristic and/
or palmitic acid) and the gamma (farnesol or geranylgeraniol) subunits. Thesemodiﬁcations not only assist the
G protein to localize to the membrane but they also help distribute the heterotrimer (Gαβγ) and the subunits
generated upon activation (Gα and Gβγ) to appropriate membrane microdomains. These proteins transduce
messages from ubiquitous serpentine receptors, which control important functions such as taste, vision, blood
pressure, body weight, cell proliferation, mood, etc. Moreover, the exchange of GDP by GTP is triggered by
nucleotide exchange factors. Membrane receptors that activate G proteins can be considered as such, but other
cytosolic, membranal or amphitropic proteins can accelerate the rate of G protein exchange or even activate
this process in the absence of receptor-mediated activation. These and other protein–protein interactions of G
proteins with other signaling proteins are regulated by their lipid preferences. Thus, G protein–lipid
interactions control the features of messages and cell physiology.
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The cellmembrane provides a structure that functions as a platform
for the assembly of many signal transduction pathways, and that
provides an additional level of regulation in cell signaling networks.
The complex dynamic structure of the plasma membrane permits
lipid–lipid and lipid–protein interactions, as well as the interaction of
lipid–protein complexes with the submembrane cytoskeleton. The
existence of membrane microdomains adds further complexity to
such interactions, as well as the messages propagated in cells through
G proteins and other non-permanent (extrinsic) membrane proteins.
Here, we aim to review the current understanding of the role of
membrane interactions in the activity of G proteins and their relevant
partners. These abundant membrane-bound receptor-coupled amphi-
tropicproteins constitute theﬁrst elements, following receptoractivation,
in various key intracellular signaling pathways. Both their interactions
withmembrane lipids and their lipid co/post-translational modiﬁcations
permit the regulation of protein function in a highly versatile manner.
Over and above the direct involvement of the alpha subunits of
heterotrimeric G proteins in signal transduction, a large number of
different GTP/GDP-binding proteins are present in eukaryotic cells. At
least ﬁve distinct families have been recognized and they also include
elongation factors active in protein biosynthesis, subunits of the signal
recognition particle (SRP) and its receptor, the ADP-ribosylation factor
(ARF) family, and the products of the Ras gene family [1]. The ﬁrst part
of this review will mainly focus on the Ras family of proteins as small
monomeric G proteins, their lipid modiﬁcations and interactions with
membranes, and their relevance in malignant transformation. The
second part summarizes our current knowledge of the interactions
between heterotrimeric G proteins and membranes as well as the role
of G protein modulators on these interactions and G protein activity.
This review highlights the relevant roles of membrane lipids and
lipid structures on the localization and activity of G proteins. These
interactions are relevant in the context of the physiology of cells, and
their alteration may lead to pathologies whose treatment could be
addressed by modifying membrane lipid composition and structure
through so-called membrane-lipid therapy.
2. Small monomeric G protein structure and their interaction with
the plasma membrane
Ras and Ras-like proteins are abundant small monomeric GTPases
foundmainly at the inner surface of the plasmamembrane, and are key
elements in complex and crucial cell signaling events. Members of this
family include Ras, Rap1, Rap2, R-Ras, Ral, Rheb, M-Ras, and TC21,
which all display distinct signaling properties [2]. At the plasma-
membrane, these proteins function as molecular switches that initiate
and regulate multiple signal transduction pathways. Their fundamen-
tal role is in coupling external stimuli with cytoplasmic and nuclear
targets, and their activation depends on their associationwith growth
factor receptors. In this way, they can regulate cell proliferation,
differentiation, and apoptosis [3].
Mammalian Ras proteins have a molecular weight of 21 kDa and,
except for the K-Ras isoforms with 188 amino acids, they all contain
189 amino acids. Mammalian cells contain three very similar Ras
genes: H-ras, N-ras, and K-ras (with splice variants A and B). In this
review, we will refer to Ras as the products of these three genes, even
though one or the other may be predominant in different cell types. At
the protein level Ras is present in all cells, although they were pro-
minent in proliferating cells.Their structure can be divided into three domains [4]:
TheGdomain (amino acids 1–166) that is 95% conserved among the
different isoforms. This region of the protein binds guanine nucleo-
tides, contains the switch 1 and switch 2 loops, and it undergoesmajor
conformational changes on GTP–GDP exchange. It also contains the
binding surfaces for effectors, exchange factors, and GAPs (GTPase-
activating proteins).
The region containing the C-terminal 24–25 amino acids forms
a poorly conserved HVR domain (hypervariable region). This amino
acid sequence undergoes direct post-translational processing. And it is
involved in plasma membrane anchoring, as well as the trafﬁcking of
newly synthesized and processed Ras from the cytosolic surface of the
endoplasmic reticulum to the inner surface of the plasma membrane.
The C-terminal CAAX motif is a region that is post-translationally
processed to generate an S-farnesyl cysteine carboxymethyl ester. The
membrane anchor is completed by one (N-Ras, R-Ras, and K-Ras4B) or
two (H-Ras) proximal S-palmitoylable cysteine residues or a polybasic
domain of six lysine residues in K-Ras4B [[5–7], Silvius, 2002 #372]. The
other isoform (R-Ras4B) is very likely palmitoylated [8]. The minimal
membrane anchors tN, tH, and tK (t = targeting motif) are sufﬁcient to
trafﬁc and anchor heterologous proteins to the plasma membrane.
The linker region of theHVR connects the anchor sequencewith the
N-terminal G-domain. As with the gamma subunit of heterotrimeric G
proteins (see below), Ras proteins have the CAAX (C = cysteine, A =
aliphatic, X = amino acid) isoprenylationmotif at the carboxy terminus.
This post-translationalmodiﬁcation favors the anchoringof proteins to
membranes, which modiﬁes the lipid structure of the latter, creating
non-lamellar prone regions. This increased HII-phase propensity fa-
vors the binding of isoprenyl moieties and induces segregation of
membrane microdomains enriched in isoprenoids. Several Ras and
Ras-like proteins are also palmitoylated near the farnesylated carboxy-
terminus. The main divergence among Ras isoforms lies in the 24
C-terminal amino acid domain, where sequence identity falls to less
than 15% [9]. This diversity provides the different isoforms of the Ras
proteins with different propensities to interact with diverse plasma
membrane lipid structures.
2.1. Lipidmodiﬁcationof Ras proteins and targeting to theplasmamembrane
The correct targeting of Ras to the inner surface of the plasma
membrane requires a series of post-translational modiﬁcations at
the protein's C-terminus. These reactions include attachment of the
isoprenoid farnesyl by farnesyl transferase to a cysteine residue (in the
case of H-, K-, and N-Ras) or geranylgeranylation by geranylgeranyl
transferase (for N- and K-Ras). Farnesylation and geranylgeranyla-
tion both occur on the same cysteine residue (Cys-186), located four
residues from the C terminus. If the CAAX box´s last residue is Ser or
Met, then the farnesyl moiety is attached and if instead it consists of a
Leu, then geranylgeranyl is attached. All Ras isoforms preferentially
undergo farnesylation, although in the presence of farnesylation in-
hibitors N-Ras and K-Ras can undergo geranylgeranylation [10]. If, in
the CAAX box, the last residue is Ser or Met, then a farnesyl moiety is
attached. If it is Leu, then a geranylgeranyl moiety is attached. H-Ras
and N-Ras can also undergo palmitoylation and, while H-Ras has two
palmitoylation sites (Cys-181 and Cys-184) and N-Ras has only one
(Cys 181), K-Ras4B appears to lack a palmitoylation site. Both far-
nesylation and geranylgeranylation are important to target Ras to the
cell membrane. Likewise, palmitoylation may also localize Ras to the
plasma membrane, as well as participating in its speciﬁc micro-
localization at the plasma membrane [7].
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because prenylation is the ﬁrst and indispensable step in the processing
of Ras proteins. This processing includes the proteolytic removal of the
last 3 amino acids followed by subsequent lipidic modiﬁcations that
promote the association of Ras to intracellular membranes. In fact, Ras
remains soluble without this initial modiﬁcation. Besides initiating
membrane attachment the farnesyl group seems to bind to speciﬁc
membrane proteins [11], possibly enhancing Ras-membrane interac-
tions or participating in the activation of Ras effector proteins. Experi-
ments with mutant constructs of H-Ras with C-terminal palmitates but
no isoprenoid, demonstrated that palmitates can nevertheless support
substantial farnesyl-independent activity [12]. Therefore, palmitate
seems to be more than just a strong form of membrane tether, and it
may have unique and dynamic roles of its own.
While classic studies indicate that all RAS proteins rely on
farnesylation and either palmitoylation or a stretch of polybasic amino
acids for stable binding tomembranes, it has been recently shown for N-
RAS and K-Ras4A that mono-palmitoylation and farnesylation are not
sufﬁcient to direct stable cell-surface localization and that altered
localization is achievedwithout changes in palmitoylation status [13]. A
third motif that is present within the linker domain of all palmitoylated
RAS HVRs is necessary for stabilizing localization to the plasma mem-
brane. This motif comprises acidic residues that stabilize palmitoylation
and basic amino acids likely to interact electrostatically with acidic
phospholipids enriched at the cell surface.
The different Ras protein isoforms interact in differentwayswith the
plasma membrane. On the one hand, H-Ras interacts transiently
with lipid rafts when bound to GDP and it aggregates in cholesterol-
insensitive, galectin-1-dependent, non-raft domains. On the other hand,
K-Ras is clustered in cholesterol-insensitive, non-raft domains that
differ from the activated H-Ras microdomains [14,15]. Electron micro-
scopy and biochemical studies suggest a new model for the micro-
organization of Ras at the plasma membrane, whereby Ras promotes
the molecular assembly of signaling microdomains. Recent NMR and
neutron-diffraction spectroscopy studies of the biophysics of Ras
membrane anchors, as well as those involving Molecular Dynamics
simulations, conﬁrmed that insertion of the lipid chains into the cell
membrane is driven by hydrophobic interactions. However, once in
place, the backbone peptide that is inserted into the lipid bilayer
contributes to the stability of the complex. Moreover, there is emerging
evidence that the palmitate anchors of Ras proteins may help drive the
formation of signaling clusters by a combination of lipid–lipid and
protein–lipid interactions with the plasma membrane [4].
2.2. Ras signaling from platforms other than the plasma membrane
Rasproteins are captured byendosomal compartments fromwhere a
signal output can also be generated. Ectopically expressed mutant Ras
proteins with defective anchoring sequences accumulate in Golgi and
endoplasmic reticulum membranes, fromwhere they are competent to
generate a signal output. The physiological signiﬁcance of these plat-
forms is not known, and it is unclearwhether they constitute important
signaling platforms for endogenous Ras [4]. Nevertheless, there is evi-
dence that lipid modiﬁcations such as isoprenylation and N- and S-
acylation also play an important roles as speciﬁc recognition elements
for protein–protein interactions, and as hydrophobic switches. As such,
they permit temporal regulation of the docking of Ras to sub-
compartments like lipid rafts, caveolae, and other cellular localizations.
Unlike farnesylation, palmitoylation of Ras-like proteins is reversible
and it therefore constitutes a key regulatory element.
2.3. Interaction of Ras with membranes
The relevance of this issue originates from various sources. The
anchors in the hypervariable region may target the Ras isoforms to
speciﬁc microdomains of the plasma membrane with different lipidand protein content. However, it is fundamental to determinewhether
these different micro-environments inﬂuence Ras signaling. Selec-
tive microdomain localization based on the structural differences in
membrane targeting domains may account for the extensive biologi-
cal differences between Ras isoforms. Therefore, insights from Ras
may extend to the microlocalization and regulation of other lipid-
modiﬁed signaling proteins. Fluorescent-labeled probes with Ras
C-terminal anchors are increasingly being used as tools for SPT (single
particle tracking) and FRET (ﬂuorescence resonance energy transfer) to
explore the dynamics ofmicro- and nano-compartmentalization in the
plasma membrane. A recent study illustrates the use of these tech-
niques to ﬁnd a new switch region that regulates H-ras membrane
orientation and signal output [16]. This example also illustrates how
the plasma membrane acts as a semi-neutral interaction partner by
spatially constraining signal conformations.
Interestingly, another recent study shows that none of the 121
genes found to be regulated uniquely by Ras signals emanating from
plasma membrane microdomains is speciﬁcally controlled by lipid
raft-anchored Ras [17].
2.4. Ras signaling
The plasma membrane provides a platform for the assembly of
proteins that belong to many signal transduction pathways and
therefore, it has the capacity to regulate cell signaling networks. An
initial step in the transduction of signals through Ras involves the
interaction of these G proteins with growth factor receptors at the cell
surface. The next steps involve interactions with exchange factors and
speciﬁc proteins that will transduce the signals in a cascade of events
that leads to the activation/inhibition of transcription factors and hence,
the regulation of different cellular processes. Ras proteins activate
several signal transduction pathways that control gene expression and
that are involved in the regulation of critical cell processes (such as cell
proliferation, differentiation and apoptosis [3]) and cytoskeleton orga-
nization. Indeed, Ras is the common upstream molecule in several
signaling pathways including the Raf/MEK/Erk cascade (also known as
theMAP Kinase or MAPK pathway), PI3K/Akt, Ral/MEKK1/JNK, and PLC/
DAG/PKC [18].While the threehighly homologousRas isoforms can each
activate these signal transduction pathways, they display different
afﬁnities for each of them [19]. The best known of these signaling
mechanisms is the MAPK (mitogen activated protein kinase) pathway,
which involves a series of cytoplasmic serine/threonine kinases. The
cascade is activated by ligandbinding to receptors thatprovoke thepost-
translationalmodiﬁcation of Ras (through palmitoylation) and its trans-
location to the membrane. Following the binding of cytokines, growth
factors, or mitogens to their appropriate cell membrane receptors, acti-
vation of the Shc/Grb2/SOS coupling complex occurs, causing the
inactive Ras to exchange GDP for GTP, to undergo a conformational
change, and to becomeactive. TheGTP-boundactiveRas can then recruit
Raf kinase to the cell membrane and this localization of Ras at the
membrane is crucial for its biological activity. Thus, the membrane
binding of Ras enables it to act as a GTP-dependentmembrane-localized
docking site for Raf, among other downstream effectors [20].
2.5. The role of protein–lipid interactions and malignant mutations in
Ras
The role of each speciﬁc lipid modiﬁcation of Ras has mainly been
inferred frommutant Ras proteins that entirely lack one or all three of
these lipids. The decreased membrane binding observed with these
mutants indicates that their primary role is in membrane binding. It is
certainly of great interest that Ras protein–lipid interactions control
cell proliferation/differentiation pathways, as key elements in signal
transduction processes. The ras genes were initially discovered due to
their highly oncogenic potential in retroviruses or human oncogenes.
Variants of the different isoforms were independently characterized
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Different mutation frequencies have been observed between the ras
genes in human cancer, inwhich K-Ras is themost frequentlymutated
Ras isoform. Given the abundance of Ras as a membrane-associated
protein and its key role in membrane receptor signaling events, it is
hardly surprising that mutations which affect the Ras proteins have
been detected in a number of cancers including pancreatic, breast,
colon, and non-small cell lung cancer. While tumorigenesis requires
multiple hits, carcinogenesis involving Ras requires little more than an
increase in Ras levels ormutations that lock Ras into its activated state.
Nevertheless, there is increasing evidence that structural changes
which transform Ras into an oncogenic protein are not sufﬁcient to
induce cancer [21].
The signal transduction activity of Ras proteins can be altered by
both cellmembrane lipids and by their own lipidicmodiﬁcations. Post-
translational modiﬁcations of Ras such as farnesylation, geranylger-
anylation, and palmitoylation are important as they represent sites for
therapeutic intervention. Indeed,mutant Ras proteins that bind poorly
to the membrane have a low transforming potential [7,22]. These facts
impelled the development of inhibitors of farnesyltransferase as
potential antitumor drugs in the 90s. Although some such compounds
showed some activity against cancer, most failed to have any real effect
because the inhibition of farnesyltransferase provokes the modiﬁca-
tion of Ras with gerenylgeraniol, a closely related isoprenoid that also
enables membrane binding [10]. In addition, it was also found that a
non-farnesylated H-Ras protein can be palmitoylated and can trigger
potent differentiation and transformation [12]. However, myristoyla-
tion of both wild-type and activated Ras is sufﬁcient to produce a
proteinwith transforming potential [23], again lending support to the
view thatmembrane localization is a key element in transformation by
Ras.
3. Heterotrimeric G protein–lipid interactions
As peripheralmembrane proteins, G proteins interact with the inner
side of the plasma membrane and form part of the signaling cascade
activated by G protein-coupled receptors (GPCR). They are comprised of
three subunits Gα, Gβ and Gγ, which are often closely associated with
the intracellular domains of GPCRs. The binding of an extracellular
agonist activates GPCRs, inducing a conformational change in its protein
structure that leads to the activation of the corresponding hetero-
trimeric G protein. As a consequence, the Gα-subunit of the hetero-
trimeric complex exchanges bound GDP for GTP and subsequently
dissociates from the Gβγ-dimer, enabling both molecular entities to
regulate the activity of their speciﬁc effectors. During this process G
proteins can be affected by lipid–protein interactions in several ways.
First, like all membrane-associated proteins, the localization and
function of G proteins is inﬂuenced by the biophysical properties of
themembranewithwhich they interact. Second, the close interaction of
G proteins with the membrane enables them to also modulate their
immediate lipid environment, thereby modifying plasma membrane
lipid structure and organization which in turn modulates binding of G
proteins to membranes. Third, in order to ensure tight membrane
attachment, the different subunits of G proteins undergo distinct co- or
post-translational lipid modiﬁcations. The nature of the lipid moiety
attached in this process dictates the speciﬁc requirements of the optimal
membrane lipid environment necessary for its correct localization and
activity. This section of the review focuses on the variety of interactions
between membrane lipids and proteins reﬂecting the complexity of
their relationship and the multitude of possible regulatory processes
involved in G protein-mediated signal transduction.
3.1. GPCR activation of heterotrimeric G proteins
A large number of hormones, neurotransmitters, chemokines,
and sensory stimuli exert their effects on cells by binding to GPCRs.Heterotrimeric G proteins located at the cytoplasmic face of the plasma
membrane are the intracellular partners of these receptors in the
generation of the cellular responses to extracellular signals. When a
ligand binds to a GPCR the receptor acts as a guanine nucleotide
exchange factor (GEF), activating a Gα subunit and promoting the
release of GDP and the binding of GTP. These modiﬁcations cause
conformational changes in Gα that induce its dissociation from the Gβγ
dimer. As a result, both the GTP-bound Gα subunit and the Gβγ dimer
independently modulate dowstream effectors. The Gα subunit has
intrinsic GTPase activity that can hydrolyze GTP to GDP, which induces
the re-association of the inactive Gα subunit with a Gβγ dimer,
terminating the signal. Recently, aswill be discussed in section 3.6, other
proteins known as activators of G protein signaling (AGS) regulate G
protein-mediated signals in theabsenceof receptor activation.Regulator
of G protein signaling (RGS) proteins help accelerate the GTPase activity
of Gα and the re-association of the inactive heterotrimer (Fig. 2). Thus,
Gβγ acts as a guanine-nucleotide dissociation inhibitor (GDI), since
whenbound toGα it slows the spontaneous rate ofGDP release [24]. The
assembly of Gα to the Gβγ subunit in its GDP-bound form allows Gα to
associate with the plasma membrane and has an important role in its
functional coupling to GPCRs. Lipid modiﬁcations of Gα subunits are
important for their membrane localization. Indeed, it is known that the
localization of the G protein heterotrimers to the plasma membrane
involves multiple processes such as post-translational modiﬁcations,
subunit assembly, and protein–membrane interactions [25–31]. As
indicated below, Gα subunits can be N-myristoylated and/or N-
palmitoylated, which helps deﬁne the localization of these proteins,
although the presence of a fatty acyl moiety (e.g., myristic acid) is not
sufﬁcient to translocate Gα subunits from the cytosolic to membrane
fractions [32–34]. Myristoylation and/or palmitoylation of Gα subunits
not only regulate their targeting to speciﬁc cell membrane regions
but also, they regulate their interaction with other signaling proteins
[35–38]. Nevertheless, all Gγ subunits are C-terminally prenylated [39]
and this lipid modiﬁcation is also important for the proper membrane
localization of the Gβγ dimer.
3.2. Lipid modiﬁcations of G proteins
Lipidation of heterotrimeric G proteins (Gαβγ) involves the co-
valent binding of a hydrophobic molecule to the signaling protein.
Three different types of lipid modiﬁcation have been described in the
case of heterotrimeric G proteins, namely myristoylation, palmitoyla-
tion and isoprenylation. These moieties participate in G protein–lipid
interactions and they are involved in the translocation of G proteins to
membranes and their further mobilization to different membrane
microdomains.
3.2.1. Myristoylation of G proteins
Myristoylation is a co-translational modiﬁcation that involves the
covalent attachment of the saturated fatty acidmyristate to a protein via
an amide bond (N-acylation) [40]. In contrast to S-acylation and
palmitoylation that are characterized by a labile thioester linkage,
the amide bond represents a comparatively stable chemical struc-
ture and it is therefore considered to be irreversible. Myristoylation is
catalyzed by the enzyme N-myristoyltransferase and it is speciﬁc to the
N-terminal glycine in proteins. The absolute requirement for a free
glycine residue at the N-terminus of the substrate protein implies that
the initiating methionine must be eliminated by a methionyl amino
peptidase prior to lipidation. However, a free N-terminal glycine residue
alone is not sufﬁcient to guarantee myristoylation, because substrate
recognition also depends on the subsequent amino acid sequence. In
particular, the nature of the sixth amino acid (considering methionine
as the ﬁrst) seems to be important in this context, and myristoylated
proteins usually contain a serine or threonine residue at this
position [41]. Consequently, subunits of the Gi family including Gαi1–
i3, Gαo, Gαz, that contain a Gly2/Ser6 motif, are potential substrates
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are not. Although N-myristoyltransferase almost exclusively catalyzes
the attachment of myristate (C14:0), it has also been found to transfer
other acyl fatty acids under certain circumstances, such as lauryl [C12:0],
(cis-delta 5)-tetradecaenoyl [C14:1(Δ5)] and (cis,cis-delta 5, delta 8)-
tetradecadienoyl [C14:2(Δ5,8)] [42]. This relaxation in speciﬁcity is
conﬁrmed by the different lipidmodiﬁcations other thanmyristoylation
observed at the N-terminal glycine of Gαt (transducin). However, this
exceptional diversity of lipidmodiﬁcations onGly2 appears to be speciﬁc
to retinal rod cells [43,44].
Lipid modiﬁcations assist peripheral proteins in their docking to
membranes by inserting a hydrophobic moiety that serves as a
membrane anchor. Indeed, mutations in Gα subunits that prevent
N-myristoylation (Gly2→ Ala2) prevent protein binding tomembranes
[45,46]. Nevertheless, the presence of a myristoyl moiety is not
sufﬁcient for stable membrane attachment [47], and moreover the
majority of Gα subunits are notmyristoylated. Therefore, it is clear that
this sort of lipid modiﬁcation must also have another function besides
simply enhancing the membrane afﬁnity of a protein. For the Gi fa-
mily myristoylation is a precondition for palmitoylation [32,48], the
secondary lipidmodiﬁcation found onGα subunits. In this context, the
role of the myristoyl group is to facilitate an initial contact with
the membrane and to direct the Gα subunit to the palmitoylation
compartment. At least in the case of Gαt, another important function of
myristoylation could be to maintain the N-terminal structure of the
corresponding Gα subunit, as recently proposed [49].
3.2.2. Palmitoylation of G proteins
Palmitoylation is a post-translational modiﬁcation that consists in
the covalent attachment of the saturated fatty acid palmitate to a
protein via a thioester bond (S-acylation). In contrast to other covalent
lipid modiﬁcations, palmitoylation is a very dynamic modiﬁcation,
because this bond is chemically labile andhas been shown to be rapidly
turned over in vivo [50,51]. Besides the palmitoylation of Ras proteins
or GPCRs [52], this lipid modiﬁcation also occurs on one or several
cysteine residues within the ﬁrst 20 amino acids of the N-terminal
region of theGα subunit, but the speciﬁc amino acid sequence required
to facilitate palmitoylation has not yet been deﬁned in detail. As an
exception to the rule it was recently found that native Gαs can also be
palmitoylated at the N-terminal glycine (Gly2), and that this lipid
modiﬁcation occurs via N-acylation [53]. The apparent dual Gly2/Cys3
palmitoylation of Gαs is similar to the myristoylation/palmitoylation
motif of the Gαi family and it has functional consequences on signal
transduction [54]. Generally, with the exception of αt and αgust all Gα
subunits undergo palmitolylation, but neither the speciﬁc palmitoyl-
transferase that catalyzes the lipidation of mammalian Gα subunits
nor the exact cellular site where this occurs have so far been
discovered. Palmitoylation of membrane proteins has in fact been
detected in several subcellular localizations and while palmitoylation
of caveolin-1 [55] and transferrin receptor [56] appears to take place at
the plasma membrane, that of viral polypeptides and glycoproteins
seems to occur in the Golgi [57,58]. Other proteins are palmitoylated
even earlier in their biosynthetic pathway (i.e. in the endoplasmatic
reticulum [59]) and it is difﬁcult to discern whether all these
compartments are true sites of palmitoylation or whether they simply
reﬂect the rapid intracellular transition through the vesicular system.
Point mutations of Gαs and Gαq aimed at impairing binding to Gβγ
dimers not only inhibited trafﬁcking to the plasmamembrane but also
their palmitoylation [60]. Conversely, restoring the plasma membrane
localization of these mutants also restored palmitoylation. These
results imply that Gα and Gβγmost likely interact before Gα reaches
the plasma membrane and that heterotrimer formation is a necessary
part of the plasma membrane targeting signal for both entities.
Disruption of the Golgi does not alter the plasma membrane
localization or palmitoylation of Gα subunits [61,62], indicating that
heterotrimer formation may take place in the endoplasmic reticulum.3.2.3. Isoprenylation of G proteins
Isoprenylation is a multi-step post-translational process that
involves covalent attachment via a chemically stable thioether bond
of either a farnesyl group, consisting of 3 isoprene repeats with a total
of 15 carbon atoms, or a geranylgeranyl group of 4 isoprenes and a total
of 20 carbon atoms. Isoprenylation is an irreversible lipid modiﬁca-
tion that has only been found on the Gγ subunit of heterotrimeric
G proteins. In this context, farnesylation occurs in Gγ1, Gγ9, and Gγ11,
whereas the remaining 9 Gγ subunits are all geranylgeranylated [63].
Isoprenylation depends on the existence of a rather simple se-
quence at the C-terminus of the protein, the so-called CAAXbox,which
determines the substrate speciﬁcity for a farnesyl or geranylgeranyl
transferase. This motif contains the cysteine to be modiﬁed (C), fol-
lowed by two aliphatic amino acids (AA) and an amino acid at the
C terminus (X), controlling the recognition by one of the two enzymes.
If the last residue of the CAAX box is serine or methionin, then the
preceeding cysteine is farnesylated, whereas in the case of leucine a
geranylgeranyl moiety is attached. Isoprenylation takes place in the
cytosol and the Gβγ dimer then translocates to the endoplasmatic
reticulum for further processing. In this cellular compartment, pro-
teolysis of the three terminal -AAX amino acids is catalyzed by the
endoprotease Ras-converting enzyme (Rce) [64], and the newly
formed C-terminal cysteine with the isoprenyl modiﬁcation becomes
a substrate for isoprenylcysteine carboxyl methyltransferase (Icmt)
[65]. The exact reason for this proteolysis andmethylation is unknown
(especially as this methylation is generally reversible), but it seems
that carboxy methylation of the last amino acid further increases its
hydrophobicity, thereby enhancing the membrane anchorage proper-
ties of the C-terminus. This might still make some sense in case of
farnesylated Gγ subunits, but the greater hydrophobicity of the ge-
ranylgeranylmoiety compared to the farnesyl group alreadymakes it a
strong membrane anchor that would not be expected to need further
enhancement to bind tightly to the membrane [27]. Nevertheless, the
tight association to intracellular membranes is not sufﬁcient to target
the Gβγ dimer to the plasma membrane, and isoprenylated pro-
teins need additional targeting signals to shuttle from the endoplas-
matic reticulum to the plasma membrane. In this context, it has
been demonstrated that the subcellular localization of the Gβγ dimer
is regulated by the presence of the Gα subunit and its trafﬁcking
pathway [66].
3.3. Biophysical properties of membranes on heterotrimeric G protein
signaling
Membrane microviscosity, or its reciprocal parameter ﬂuidity, was
one of the ﬁrst parameters used to demonstrate the relationship
between the biophysical properties of the lipid bilayer and the activity
of associated proteins [67]. Membrane ﬂuidity depends on the lipid
composition of the membrane, especially on the type of fatty acid
moieties in the membrane phospholipids and the amount of cho-
lesterol. In general, as the degree of unsaturated fatty acid moieties
increases in membrane phospholipids, so does the ﬂuidity of the
membrane [68]. It has been shown that metabolic disorders or
nutritional interventions can alter the lipid composition of the mem-
brane and as a consequence, its ﬂuidity [69,70]. In fact, diseases in
which G protein-mediated signaling plays an important role, such
as hypertension and Alzheimer disease, have been associated with
altered membrane ﬂuidity [71,72]. Although changes in membrane
ﬂuidity are obviously related to certain illnesses, this parameter is not
very helpful in carrying out a profound characterization of the
biophysical properties of the membrane. This is in part because it
still considers the plasma membrane as a homogeneous structure, as
depicted by the traditional Singer–Nicolson model.
While the lipid–protein interactions between G proteins and
lamellar-prone membranes have been studied intensely [73], little
attention has been paid to the potential interactions with nonlamellar-
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affect the physical properties of biomembranes by inducing alterations
in the intrinsic curvature of the monolayer, in the lateral surface pres-
sure, and in the hydration of membranes [74]. Cell membranes are
usually rich in phosphatidylethanolamine (PE), a nonlamellar prone,
inverted hexagonal (HII) phase inducing lipid that is mainly found at the
inner face of the plasma membrane [75], and thus determines the
properties of the normal site for G protein binding. The physiological
amount of PE in natural membranes is sufﬁciently high to induce
negative curvature strain in vivo, which might be stabilized by the
presence of certain membrane proteins [76]. It has been demonstrated
that the greater the hexagonal-phase propensity, the higher the afﬁnity
of heterotrimeric αi proteins for the membrane [25]. Consequently,
membrane domains with enhanced negative curvature strain could act
as a platform for the interaction of these peripheral proteins with other
signaling proteins. This idea is in agreement with the observed loss of G
proteins from plasma membranes after disruption of nonlamellar HII
structures by daunorubicin [26].
As G protein-mediated signaling operates as a signal ampliﬁca-
tion cascade where every agonist-bound GPCR activates numerous
G proteins, efﬁciency would be enhanced if a large number of inac-
tive heterotrimeric G protein molecules were readily available in the
proximity of the receptor. Indeed, an early study of signal transduc-
tionkinetics inhumanplateletmembranes suggests that aboutone third
of theα2-adrenergic receptors seemtobe coupled toGαi prior to agonist
binding [77]. In general, transmembrane peptides with α-helical
structures, such as the membrane-spanning regions of GPCRs, can
promote the formation of hexagonal phases [78], and other data indicate
that GPCRs seem to display similar lipid phase preferences as
heterotrimeric G proteins. It was proposed that lipids with a negative
spontaneous curvature favor the elongation of the G protein-coupled
photoreceptor rhodopsin during the activation process. This was
explained by the fact that they facilitated the conformational change
of rhodopsin to its activated state in model membranes [79]. Moreover,
measuring the interaction of this receptor and its corresponding G
protein transducin (αt) in lipid bilayers demonstrated that PE markedly
increased receptor afﬁnity forαt upon light activation, while the afﬁnity
ofαt for dark-adapted rhodopsin remained unchanged [80]. By contrast,
in pure lamellar PC bilayers the afﬁnity of αt for light-activated
rhodopsin is substantially lower. Retinal rod outer segmentmembranes,
where rhodopsin is found, contain about 50% docosahexaenoic acid
(DHA), which is a fatty acid with a strong propensity to induce curved
structures [81]. Nevertheless, the observation that rhodopsin activation
can also be supported by other non-lamellar lipids, such as the
hexagonal-pronePE, indicates that thephysical curvature stress induced
by these lipids is more likely to facilitate the conformational change of
this GPCR rather than a direct lipid-speciﬁc reaction between DHA and
rhodopsin. In fact, a pronounced restructuring of membrane lipids
during photoactivation of rhodopsin occurs, which provides strong
evidence for its dynamic interaction with the lipid phase of the disc
membranes [82]. It might be possible that GPCRs reorganize the lipid
environment around them during agonist activation, and that the
presence of nonlamellar-prone membrane lipids is indispensable for
them to produce this conformational change. Thus, hexagonal phase-
forming membrane lipids seem to fulﬁll a dual role in signal trans-
duction, by inducing the co-localization of the ﬁrst signaling compo-
nents, and by participating in GPCR activation.
On the other hand, GPCRs and heterotrimeric G proteins have also
been found in membrane domains with strong lamellar membrane
organization, such as lipid rafts and caveolae. Lipid rafts are deﬁned
membrane regions in a liquid-ordered (lo) state and caveolae are
a subtype of these microdomains, whose ﬂask-shaped membrane
invaginations are stabilized by a matrix of caveolin molecules that
serve as scaffolds for a variety of different proteins of the GPCR signaling
cascade [83]. For example, in cardiomyocytes the G protein-coupled β2-
adrenoreceptor (β2-AR) and Gαi were found in caveolae, although theβ1-AR and Gαs were predominantly present in non-caveolae regions of
the plasma membrane of these cells [84]. Furthermore, the correct
localization of the β2-AR in caveolaewas essential for efﬁcient signaling
of this receptor subtype [85]. In the case of the β3-AR differential
membrane localizationmight be even true for the two splice variants of
this receptor, because there is evidence that the β3A-AR but not the β3B-
AR resides in caveolae [86]. As a consequence, in CHO cells the β3A-AR
exclusively couples to Gαs, whereas the β3B-AR couples to both Gαs and
Gαi [87], a coupling preference which can be easily eliminated by
disruption of raft-like microdomains with ﬁlipin. Although Gq has also
been found enriched in detergent-resistant membrane areas of human
platelets, this was only observed after activation of the corresponding
signaling pathway by thrombin [88]. A similar activation-dependent
translocationwas also true for Gαt, which only translocated to lipid rafts
upon activation [89]. Together, these results indicate that membrane
compartmentalization of GPCR signaling is obviously complex and
inﬂuenced by several parameters, such as the type of GPCRor G protein,
the downstream effectors, and maybe also the speciﬁc cell type.
Consequently, lipid rafts and caveolae may enhance or attenuate
interaction of speciﬁc signaling molecules by promoting or hindering
their spatial proximity. In addition, interpretation of scientiﬁc literature
is often difﬁcult, because a considerable amount of published articles
only discriminate thesemicrodomains by their general physicochemical
property in terms of “detergent-resistant” membrane areas or by ex-
perimental cholesterol depletion with β-cyclodextrin, which in fact
would apply to both lipid-rafts and caveolae.
Biophysical studies demonstrated, that in contrast to G protein
heterotrimers, the activated monomeric αi-subunit showed a marked
preference for pure lamellar structures [25], which would provoke the
rapid exit of activated αi-monomers from a receptor environment
where the hexagonal-phase propensity is increased. Mobilization of
the Gα protein subunit far from the receptor environment may
facilitate its interaction with effector proteins (e.g. adenylyl cyclase)
located in other membrane areas. This idea is further strengthe-
ned when considering that a large number of effector proteins are
localized to lipid rafts. Both Gαi and Gαs have been found in lipid rafts
[90] and some G protein subunits indeed partially co-localized with
adenylyl cyclase in membrane structures containing caveolin [91].
However, most G proteins resided in irregular structures within the
plasmamembrane that have not beenmorphologically deﬁned.When
considered in conjunction with the ﬁnding that certain Gα subunits
only translocate to lipid rafts upon activation, lipid rafts appear to
represent platforms whose speciﬁc biophysical properties are able to
enhance the effectiveness of the second step of the signaling cascade,
trapping activated Gα-subunits and augmenting the spatial proximity
between them and their effectors.
On the other hand, dissociated Gβγ-dimers still maintain a high
afﬁnity for membranes with a hexagonal propensity [25], which may
also inﬂuence their distribution in native membranes. The general
observation that prenylated proteins are normally not localized to
lipid rafts [92] has also been conﬁrmed for Gβγ-subunits, which are
excluded from synthetic lipid rafts [35]. This indicates that the Gβγ-
dimer most probably determines the lipid preference of heterotri-
meric G proteins. In other words, the Gβγ-dimer determines the
preference of complete Gαβγ heterotrimers for the hexagonal-phase,
thereby masking the lamellar membrane afﬁnity of the Gα-subunit.
Therefore, one of the functions of the Gβγ-dimer could be to transport
Gα-subunits to the vicinity of the receptor, making them available for
immediate activation (Fig. 1).
3.4. Effects of G proteins on biophysical membrane properties
The fact that the interaction between membrane lipids and
proteins is not unilateral but that it occurs in both directions is often
overlooked. It is obvious that the association of G proteins with the
plasmamembranemakes them susceptible to their lipid environment,
Fig. 1.Membrane structure and GPCR-associated signaling. (Upper panel) GPCRs (R) induce the formation of hexagonal-phases (H) in their vicinity and these nonlamellar membrane
regions attract heterotrimeric (inactive) G proteins, driven by the Gβγ-subunit. (Lower panel) Upon agonist (A) binding, several heterotrimeric G protein molecules are activated by
one GPCR (R) molecule. Thus, Gα-subunits dissociate from the Gβγ-dimers and they are targeted to special regions of the plasma membrane, such as lipid rafts, due to their greater
afﬁnity for bilayers with highly lamellar organized lipids. There, they may activate their corresponding effector proteins (E1). Gβγ-dimers remain in nonlamellar-prone regions,
where they can interact with their speciﬁc effectors (E2) and guide GRKs directly to the receptors. The latter would promote GPCR phosphorylation leading to receptor inactivation.
Table 1
C-terminal region of various subunits of GRK, Gγ and Ras proteins
Consensus key: ⁎ single, fully conserved residue (isoprenylation site); : conservation of
strong groups; · conservation of weak groups; x homology for members of more than
one protein family; x no consensus.
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function. In turn, G proteins also seem to be capable of modulating
lipid structure and the organization of themembranewith which they
interact. An interesting property of the lipid moieties of Gγ subunits
was recently discovered given that Gγ subunits are post-translation-
ally lipidated with the isoprenoids farnesol or geranylgeraniol. These
isoprenyl moieties alone have the propensity to segregate in a
multidomain system formed by a lamellar crystalline (Lc) phase, and
lipid structures enriched in isoprenoid form when added to model
membranes containing PE [93]. In addition, they promote tempera-
ture-dependent growth of the hexagonal phase that can coexist
within the lamellar Lc phase. Similar behavior could be observed in
experiments with these isoprenyl moieties bound to the carboxy-
terminal peptide of the Gγ2 subunit [30]. Therefore, it is likely that not
only does the Gβγ-dimer display a preference for areas enriched in
nonlamellar lipids in vivo, but that it is also actively involved in the
formation or stabilization of microdomains with intrinsic negative
curvature. It is tempting to speculate that these biophysical char-
acteristics of the Gβγ-dimer could also be important for GPCR
desensitization following agonist-mediated activation. Dissociated
Gβγ-dimers can bind to the GPCR kinases (GRKs) that phosphorylate
and inactivate GPCRs. The preference of the Gβγ-dimer for the
nonlamellar membrane environment, where membrane receptors are
also located, could direct these kinases to their target, provoking the
termination of the signal initiated by agonist binding to the receptor
(Fig. 1). This hypothesis is strongly supported by the involvement of
membrane lipids other than PC in the regulation of GPCR phosphor-
ylation and desensitization. Indeed, with the exception of PC, other
membrane lipids that either provide nonlamellar propensity or a net
charge to the bilayer can actually regulate GRK activity [94]. Notably,
retinal GRK1 also has a farnesyl moiety covalently attached to its
carboxy terminal domain, like the Gβγ-dimer, and the presence of this
isoprenoid group is essential for light-dependent membrane associa-
tion of GRK1 [95]. Amutant unfarnesylated form of the kinase remainsin the soluble fraction following light exposure and displays a reduced
capacity to phosphorylate rhodopsin. In contrast, a mutant kinase
bearing a more hydrophobic geranylgeranyl (C20) isoprenoid moiety
was constitutively associated with the membrane, although it phos-
phorylated rhodopsin at a rate comparable towild-type (farnesylated)
GRK1 [95]. Thus, a speciﬁc in vivomodiﬁcation (farnesylation) ensures
that membrane association of GRK1 only occurs in the presence of its
activated receptor substrate. This lipid modiﬁcation of GRK, common
to Ras proteins and the gamma subunit of G proteins, is reﬂected in the
amino acid homology found in the carboxy-terminal region of all
these proteins (Table 1). However, GRK 4 and 6 are palmitoylated
rather than farnesylated [96,97], making it possible that these kinases
are regulated in a different way by other membrane lipids.
In general, a palmitate moiety favors the localization of proteins in
membrane areas with a highly ordered lamellar state (lo). Therefore,
GRK 4 and 6 may have a stronger afﬁnity for membrane domains with
this biophysical property, in agreement with their localization in
membrane regions of this kind, i.e. caveolae. However, targeting of
GRKs to caveolae seems to depend rather on a direct interaction with
caveolins than on the type of lipid modiﬁcation. In fact, Carman et al.
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caveolin by a consensus caveolin-bindingmotif present in the pleckstrin
homology (PH) domain and in the N-terminus of GRKs [98]. Interaction
between GRKs and caveolin via this motif, being present in all GRKs,
results in potent inhibition of GRK activity and may be necessary to
suppress basal GRK activity. In this scenario, palmitoylation of GRKs
could contribute to co-localization of these kinases and caveolins, which
would facilitate their further protein–protein interaction.
3.5. Subcellular localization of G proteins
Heterotrimeric G proteins are signaling molecules involved in the
propagation of extracellular stimuli to the interior of a cell. Therefore,
G proteins are targeted to the plasma membrane after transcription
and lipidation in order to exert this function. Nevertheless, there is
substantial evidence that these signaling molecules are additionally
able to translocate to intracellular compartments upon agonist stimu-
lation. The best characterized subunit of heterotrimeric G proteins in
this sense is Gαs, for which a movement from the plasma membrane
to the cytosol after agonist stimulation has been demonstrated
[99,100]. This internalization is not mediated by clathrin-coated
vesicles, which form part of the typical internalization mechanism
for most G protein-coupled receptors, including the β2-adrenoceptor,
although the time-course of this process is similar to that of GPCRs
[101]. A study carried out in living cells indicated that Gαs may be
internalized via lipid rafts [102]. Furthermore, it has been shown that
agonist-activated trafﬁcking of Gαs to the cytoplasm is reversible, so
that the internalized G proteins are able to return to the plasma
membranewhen receptor activation is terminated [103]. Interestingly,
a recent work provided evidence that shuttling of heterotrimeric G
proteins between the plasmamembrane and intracellular membranes
can also take place without activation in a vesicle-independent way
[104]. However, the exact intracellular trafﬁcking pathways are still
poorly understood, and there is still a debate about whether
internalized Gαs is truly cytosolic or remains bound to membrane
vesicles within the cytosol. Apart from Gαs, also Gαt and Gαq are able
to translocate to the cell interior after stimulation. Rapid internaliza-
tion of photoreceptor-speciﬁc G protein, transducin, and its redis-
tribution from rod outer segments to other cellular compartments
after activation is an important physiological adaptation mechanism
to light exposure, allowing these cells to maintain their function in a
much wider range of light intensity [105]. Similarly, upon activation of
the angiotensin II receptor, a considerable fraction of Gαq/11 appeared
in the cytosolic fraction of the cell within a few minutes [106].
Palmitoylation is the only lipid modiﬁcation of most Gα subunits
(with exception of the Gi protein family, whose members are
additionally myristoylated, and Gt, being only myristoylated) and at
the same time the main membrane anchor for these peripheral
membrane proteins. These and the fact that palmitoylation is a very
dynamic lipid modiﬁcation has strengthened the hypothesis that
palmitoylation turnover is a key mechanism in the observed move-
ment of Gα subunits to the cytosol, because the loss of this hydro-
phobic membrane anchor through depalmitoylation could easily
explain the observed translocation. Actually, it has been demonstrated
that activation of Gα by the appropriate GPCR increases palmitate
turnover [32]. Irrespective of whether depalmitoylation is responsible
for cytosolic translocation, the extent of Gαs depalmitoylation upon
β2-adrenergic receptor activation was inversely correlated with the
efﬁcacy in stimulating adenylyl cyclase, underlining the functional
importance of this cellular process for signal transduction [107].
Much less information has been gathered about the activation-
dependent redistribution of the Gβγ dimer from the plasma mem-
brane. One study demonstrated co-localization of the Gβγ dimer with
Gαs in small vesicular structures [101], whereas others found it asso-
ciated to the Golgi complex [108] after stimulation. The extent and
time course of βγ-dimer internalization varies widely, which is partlyattributed to the kind of lipid modiﬁcation on the gamma subunit, but
also depends on its interaction with the receptor and the type of the
Gα subunit found in the heterotrimeric complex [109,110]. In this
context, a recent, very comprehensive study in living cells including all
known gamma subunits, revealed that not all of these subunits are
able to internalize upon agonist stimulation [111]. The subunits Gγ1,
Gγ9 and Gγ11 were able to rapidly translocate to the Golgi complex,
whereas Gγ5 and Gγ10 moved slowly to this membrane complex. On
the other hand, Gγ13 translocated rapidly to the endoplasmatic
reticulum. In contrast, the subunits Gγ2–4, Gγ7,8 and Gγ12 did not
trafﬁc to intracellular sites after agonist stimulation.
A ﬁnal conclusion concerning the physiological function of G protein
internalization in cell biology would surely be premature, but most of
the data gathered point to an important role in the desensitization
process following GPCR activation. Besides, basal cycling of inactive
heterotrimeric G proteins between cell and intracellular membranes
may be essential to maintain an intracellular pool of these signaling
molecules and to prepare (sensitize) the cytoplasmatic surface of cell
membranes for activation. Whether subcellular localization of G pro-
teins has more yet undiscovered functions remains to be investigated.
3.6. Receptor-independent activators of G protein signaling
During recent years, alternative forms of regulating signaling
through heterotrimeric G proteins have been studied, forcing us to
broaden our perspective regarding the role of G proteins as “signaling
switches” [112]. In this regard, several accessory proteins that can
interact with G proteins independently of receptor activation have
been characterized through different approaches. A direct activator of
G proteins was partially puriﬁed from NG108-15 cells, which acts on
both hetrotrimeric brain G protein and free Gα in a manner distinct to
that of receptors [113]. Yeast-based screens have also identiﬁed
receptor-independent activators of heterotrimeric G protein signaling
[114], including the so-called activators of G protein signaling (AGS).
These proteins have been classiﬁed into different groups depending
on their role in signal transduction. AGS1, previously identiﬁed as a
dexamethasone-inducible Ras family GTPase [115], is the only
member of the ﬁrst group and has been characterized as a putative
guanine nucleotide exchange factor (GEF) for Gαi subunits [116] (later
renamed RASD1 by the Human Genome Organization [HUGO] Gene
Nomenclature Committee). This protein contains a Ras-like domain
with extensions in the N- and C-terminal regions containing
consensus farnesylation motifs with similar characteristics to those
of G protein farnesylation [112]. Like the G protein activator partially
puriﬁed from NG108-15 cells, AGS1 increases GTPγS binding to Gαi1
and Gαi2 monomers as well as to G protein heterotrimers puriﬁed
from the brain (Fig. 2). Recently, another protein called Resistant to
Inhibitors of Cholinesterase 8A (Ric8A) was identiﬁed as another
receptor-independent GEF that exclusively acts on free Gq/i/o α-
subunits [117].
The second group of AGS proteins is also called GoLoco or GPR
motif-containing proteins because they contain at least one GPR or
GoLoco domain. TheseGPRmotifs have been discoveredwithin several
proteins of diverse nature, such as C. elegans GPR 1/2 [118–120],
Drosophila PINS [121,122] and the mammalian Purkinje cell protein-
2 (Pcp2/L7) [123,124], Rap1GAPII [125,126], AGS5 (LGN or mPINS)
[127–130], AGS3 [130–132], AGS4 [133,134], Wave [135], AGS6
(RGS12) and RGS14 [136,137]. AGS3-5 have been renamed by
the HUGO Gene Nomenclature Committee as G protein signaling
modulator (GPSM) 1–3, respectively, and PCP2 is now called GPSM4
[24]. The GPR motif is generally selective for Gαi subunits in the GDP-
bound form, and the interaction slows the spontaneous GDP release
by Gα and it interferes with Gβγ binding to Gαi [138] (Fig. 2). Thus,
these proteins can behave as guanine nucleotide dissociation inhibitor
(GDI) for Gα and can accelerate the rate of heterotrimer dissociation
Gαβγ.
Fig. 2. G protein activation by receptors and AGS proteins. (A) G protein heterotrimers (Gαβγ) can be activated by GPCRs (green), inducing the exchange of GDP by GTP. Moreover,
some activators of G protein signaling (AGS1) can promote the exchange process in the abscence of receptor activation, whereas regulators of G protein signaling (RGS) and GTPase
activating proteins (GAP) increase the rate of GTP hydrolization. (B) Alternatively, other G protein regulators can also activate G proteins signaling in the absence of receptor-mediated
activity and without promoting nucleotide exchange.
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interactions
The interactions between proteins containing GPR-motifs and Gαi
subunits can be regulated by restricting the subcellular distribution of
these proteins to speciﬁc microenvironments. In this sense, both AGS3
and AGS5 (LGN) contain a tetracopeptide (TPR) motif, a highly degen-
erate sequence found in a large number of proteins that serves
different functions [112]. Thus, TPR motifs contribute to target the
protein to different microdomains within the cell via protein–protein
interactions [139]. TPR-interacting proteins can inﬂuence the sub-
cellular localization of AGS3 and 5 and/or their interaction with Gαi
subunits. Neither AGS3 nor LGN have any apparent hydrophobic
domains or consensus sequences for acylation that would mediate
their membrane association [140]. However, the TPR regions of the
Drosophila AGS3 homologue PINS play a key role in its localization to
the cell membrane. Indeed, these domains are required for transloca-
tion of the protein to a speciﬁc membrane region of the neuroblast,
which is achieved by the binding of the protein INSCUTEABLE to the
TPR domains in PINS [121,122]. It has been shown that the correct
targeting of the complex PINS-Gαi to the apical cortex of Drosophila
neuroblasts is essential to induce asymmetric cell division, a mechan-
ism to achieve cellular diversity during development. In this context, a
proper positioning of the mitotic spindle is an essential step for
asymmetric division. Although the molecular bases of this mechanism
are not fully understood, their spatial and temporal activation is
controlled by heterotrimeric G protein signaling as well as proteins
containing the GPR motif. In C. elegans, the interaction of GPR1/2 and
Gα at the posterior cortex is critical for proper asymmetric positioning
of the mitotic spindle. Furthermore, the role of the mammalian GPR
proteins LGN and AGS3, G-proteins and possibly other accessory
proteins, in cell division and polarity in higher organisms is still under
investigation. Recent reports indicate important roles for theseproteins in asymmetric cell division of neuronal precursors, retinal
progenitors and epidermal cells, and in cell divisions that occur in the
absence of polarity cues [112].
AGS3 is one of the best AGS proteins studied to date and two
isoforms of this protein have been identiﬁed: the AGS3-long form and
a truncated version named AGS3-short. The major difference between
them is that AGS3-short lacks the seven TPR motifs of the amino-
terminal region of AGS3-long, which affects its cellular distribution. As
such, confocal microscopy studies indicate that while AGS3-short is
diffusely distributed across the cytoplasm of the cell, AGS3-long
adopts a punctuate distribution that reﬂects its localization to deﬁned
membrane microdomains. Therefore, the TPR motifs play a key role in
the localization of AGS3 as further reﬂected by the segregation of AGS-
short mostly to the cytosolic fraction following subcellular fractiona-
tion, while AGS3-long appears in both the crude membrane and
cytosolic fractions. Interestingly, interaction of AGS3-short with G
proteins also inhibits guanine nucleotide exchange and the transloca-
tion of AGS3-short to membranes [139].
Hence, most cellular AGS3 is cytosolic although a small subpopula-
tion is found inmembrane fractions [138,140,141]. It is not known how
AGS3 associates with membranes, and while the TPR domains may be
implicated as mentioned above, other possible binding partners may
also participate in this process. Membrane expressed AGS3 does not
appear to interfere with receptor-Gi protein coupling [142] although
cytosolic AGS3 can interact with membrane-associated Gαi1 sub-
units to remove them from their native membrane environment.
Thus, cytosolic AGS3 interferes with receptor-Gi protein coupling by
sequestering Gαi and blocking its membrane association during
reconstitution. Furthermore, cytosolic AGS3 blocks the membrane
association of Gαi1 subunits, but has no effect on the membrane
association of Gβγ subunits. However, when cytosolic AGS3 associates
with the membrane it loses the capacity to interfere with receptor-G
protein coupling. Several studies indicate that assembly with Gβγ
1649O. Vögler et al. / Biochimica et Biophysica Acta 1778 (2008) 1640–1652drives the localization of Gα to the plasma membrane or to speciﬁc
membrane domains [25,27,28,31]. Recently, a model was described in
which all three G protein subunits are synthesized in the cytosol and
that Gα and Gβγ bind to each other before they translocate to the
plasma membrane [27]. Since AGS3 can compete with Gβγ subunits
for Gαi, cytosolic AGS3 may disturb the assembly of Gβγ with Gα
subunits and thereby decrease the amount of Gα protein at the
plasma membrane, which may inﬂuence signaling pathways regu-
lated by Gβγ.
The interaction of AGS3 with G proteins can be also regulated by
phosphorylation of the GPR motif by the serine-threonine kinase
LKB1, blocking its interaction with Gαi [143]. Similarly, phosphoryla-
tion close to the GPRmotif of RGS14may inﬂuence its interactionwith
Gαi [144]. RGS14 interacts with proteins of the heterotrimeric and
monomeric G protein pathways through its multiple GPR domains
[145]. In addition to its N-terminal RGS domain, RGS14 also contains a
C-terminal GPR motif that acts as a GDI for Gαi1 and Gαi3 [146,147].
However, when Gαi and Gβγ are appropriately modiﬁed with lipids,
the heterotrimer can not be disrupted by RGS14, indicating that only
free Gαi is a substrate for the GPR domain of RGS14. Alternatively,
RGS14 might require another protein to exert its effects on hetero-
trimeric G proteins. The resistance of the heterotrimer to the GDI
activity of RGS14 depends on the presence of lipid modiﬁcations on
both the Gαi and Gβγ subunits. However, myristoylation of Gα and
prenylation of Gγ are required for the high afﬁnity interaction of Gα
and Gβγ [148,149]. In transducin (Gαt), the Gα acyl chain appears to
bind co-operatively with the Gγ farnesyl moiety to model membrane
lipids [150]. Thus, lipid–lipid interactions also participate in the
association of the subunits of oligomeric proteins by regulating their
orientation, providing productive protein interaction surfaces for their
ﬁnal binding. Thus, in the absence of lipid–lipid interactions, the
afﬁnity of Gα forGβγ is reduced, enabling RGS14 to competewithGβγ.
This is supported by other studies, indicating that GPR peptides are
able to physically disrupt the heterotrimeric complex when G proteins
lack some lipid modiﬁcations. Indeed, this occurs with a peptide
derived fromAGS3 that interferes with the association of the G protein
heterotrimer when the Gαi-subunit is not myristoylated [138]. More-
over, it has been shown that a peptide corresponding to theRGS14-GPR
motif prevents the formation of heterodimers containing non-
lipidated G protein subunits [151]. In other studies, using lipidated G
protein subunits, a peptide derived from AGS3 has been shown to
induce heterotrimeric subunit dissociation, but the excess of peptide
over theGproteins used in these experiments probablydoes not reﬂect
a physiological situation [152]. Overall, it seems that G protein lipid
modiﬁcations also play an important role determining the effect of the
GPR-containing proteins in these signaling pathways.
4. Conclusions
The purpose of this review was to highlight how protein–lipid
interactions of monomeric and trimeric G proteins with membranes
inﬂuence their activity. We also described the role of lipid modiﬁca-
tions and membrane lipid–protein interactions in the induction of
canonical and alternative G protein signaling pathways, independent
of receptor activation. During recent years, the interactions between G
proteins and membranes have been shown to be involved in
controlling cell signaling. These interactions also regulate the way G
proteins propagate signals and add versatility to themessages received
bycells. In addition, signal processing via heterotrimeric G proteins has
been challenged with alternative and unexpected regulatory mechan-
isms based on the identiﬁcation of new proteins. The functional roles
associated with these new proteins identify novel areas of research
that mostly remain to be addressed. GPCRs and associated proteins are
important in cell signaling and human physiology, controlling im-
portant functions and inﬂuencing the etiology of some diseases.
Therefore, it is not surprising that over a half of all drugs currentlyunder development are targeted to these receptors. In this context,
membrane lipid composition and structure regulates GPCR-associated
signaling and therefore, membrane lipid regulation can be used to
deﬁne new therapeutic approaches such as membrane–lipid therapy
[153].
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